LifeVantage Corporation (LFVN)
NASDAQ: LFVN · Real-Time Price · USD
12.52
-0.03 (-0.24%)
At close: Aug 1, 2025, 4:00 PM
12.58
+0.06 (0.48%)
After-hours: Aug 1, 2025, 4:00 PM EDT
United States Steel Revenue
LifeVantage had revenue of $58.44M in the quarter ending March 31, 2025, with 21.13% growth. This brings the company's revenue in the last twelve months to $222.35M, up 8.22% year-over-year. In the fiscal year ending June 30, 2024, LifeVantage had annual revenue of $200.16M, down -6.20%.
Revenue (ttm)
$222.35M
Revenue Growth
+8.22%
P/S Ratio
0.69
Revenue / Employee
$1,001,563
Employees
222
Market Cap
157.60M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 200.16M | -13.23M | -6.20% |
Jun 30, 2023 | 213.40M | 7.04M | 3.41% |
Jun 30, 2022 | 206.36M | -13.82M | -6.28% |
Jun 30, 2021 | 220.18M | -12.73M | -5.47% |
Jun 30, 2020 | 232.92M | 6.96M | 3.08% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 685.09B |
Costco Wholesale | 268.78B |
PepsiCo | 91.75B |
The Procter & Gamble Company | 84.28B |
Unilever | 70.19B |
Anheuser-Busch InBev | 58.52B |
The Coca-Cola Company | 47.06B |
Philip Morris International | 39.06B |
LFVN News
- 8 days ago - LifeVantage To Open Iceland Market - GlobeNewsWire
- 10 days ago - LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System™; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡ - GlobeNewsWire
- 11 days ago - The LifeVantage Advantage: High Retention, High Returns - Seeking Alpha
- 17 days ago - LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campaign and Incentive to Drive Global Growth - GlobeNewsWire
- 3 months ago - LifeVantage Corporation (LFVN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - LifeVantage Declares Quarterly Dividend - GlobeNewsWire
- 3 months ago - LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025 - GlobeNewsWire
- 3 months ago - LifeVantage: Activation Of Shareholder Value - Seeking Alpha